{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:50:32Z","timestamp":1791597032539,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"Division of Intramural Research","doi-asserted-by":"publisher","award":["ZIALM240126"],"award-info":[{"award-number":["ZIALM240126"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["Z01-BC 006150"],"award-info":[{"award-number":["Z01-BC 006150"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.isci.2026.117376","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:00:09Z","timestamp":1788458409000},"page":"117376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SCLC TumorMiner: A genomics platform for small cell lung cancer precision oncology"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7116-508X","authenticated-orcid":false,"given":"Fathi","family":"Elloumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Dhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Taniyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustin","family":"Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghsin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Tehim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Raffeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Aldape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Redon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshan","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Reinhold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirit","family":"Aladjem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaydira","family":"Del Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.117376_bib1","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1038\/s41467-025-64509-5","article-title":"Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling","volume":"16","author":"Thomas","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117376_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117376_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","article-title":"Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data","volume":"19","author":"Rudin","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117376_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108296","article-title":"SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures","volume":"33","author":"Tlemsani","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117376_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"39","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117376_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cllc.2018.12.019","article-title":"Advancements in Small-cell Lung Cancer: The Changing Landscape Following IMpower-133","volume":"20","author":"Pacheco","year":"2019","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.isci.2026.117376_bib7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","article-title":"Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial","volume":"394","author":"Paz-Ares","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.117376_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ccell.2024.01.010","article-title":"Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade","volume":"42","author":"Nabet","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117376_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2023.12.004","article-title":"Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies","volume":"187","author":"Liu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.117376_bib10","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1158\/1078-0432.CCR-17-0443","article-title":"Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (SLFN11) Expression with Class I Histone Deacetylase Inhibitors","volume":"24","author":"Tang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117376_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102953","article-title":"ASCL1, NKX2-1, and PROX1 co-regulate subtype-specific genes in small-cell lung cancer","volume":"24","author":"Pozo","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.117376_bib12","doi-asserted-by":"crossref","first-page":"31236","DOI":"10.1074\/jbc.M109.048694","article-title":"Cooperative transcriptional regulation of the essential pancreatic islet gene NeuroD1 (beta2) by Nkx2.2 and neurogenin 3","volume":"284","author":"Anderson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117376_bib13","doi-asserted-by":"crossref","first-page":"33381","DOI":"10.1074\/jbc.M110.147215","article-title":"Pax6 controls the expression of critical genes involved in pancreatic alpha cell differentiation and function","volume":"285","author":"Gosmain","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2026.117376_bib14","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.7150\/thno.54023","article-title":"Semaphorins as emerging clinical biomarkers and therapeutic targets in cancer","volume":"11","author":"Mastrantonio","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.isci.2026.117376_bib15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1101\/gad.314815.118","article-title":"POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer","volume":"32","author":"Huang","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.isci.2026.117376_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41586-018-0393-7","article-title":"A revised airway epithelial hierarchy includes CFTR-expressing ionocytes","volume":"560","author":"Montoro","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117376_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-025-09503-z","article-title":"Basal cell of origin resolves neuroendocrine-tuft lineage plasticity in cancer","volume":"647","author":"Ireland","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117376_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41586-022-04842-7","article-title":"OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage","volume":"607","author":"Wu","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.117376_bib19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41467-025-55936-5","article-title":"Tracheal tuft cells release ATP and link innate to adaptive immunity in pneumonia","volume":"16","author":"Abdel Wadood","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117376_bib20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jtho.2022.06.004","article-title":"POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC","volume":"17","author":"Baine","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.isci.2026.117376_bib21","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1038\/s41467-022-30416-2","article-title":"A conserved YAP\/Notch\/REST network controls the neuroendocrine cell fate in the lungs","volume":"13","author":"Shue","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117376_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105603","article-title":"DLL3 regulates Notch signaling in small cell lung cancer","volume":"25","author":"Kim","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.isci.2026.117376_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","article-title":"MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate","volume":"38","author":"Ireland","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117376_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrc.2017.87","article-title":"Small-cell lung cancer: what we know, what we need to know and the path forward","volume":"17","author":"Gazdar","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117376_bib25","first-page":"2924","article-title":"Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties","volume":"45","author":"Gazdar","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117376_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005895","article-title":"Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer","volume":"12","author":"Jiang","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.isci.2026.117376_bib27","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1038\/s41467-018-06162-9","article-title":"Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer","volume":"9","author":"Wagner","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117376_bib28","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s12276-022-00794-0","article-title":"Structural, molecular, and functional insights into Schlafen proteins","volume":"54","author":"Jo","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.isci.2026.117376_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2019.05.009","article-title":"Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies","volume":"201","author":"Murai","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2026.117376_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.15529","article-title":"Schlafen 11 Expression in Patients With Small Cell Lung Cancer and Its Association With Clinical Outcomes","volume":"16","author":"Masuda","year":"2025","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.isci.2026.117376_bib31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jtho.2024.12.028","article-title":"Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03","volume":"20","author":"Dowlati","year":"2025","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.isci.2026.117376_bib32","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMoa2307980","article-title":"Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer","volume":"389","author":"Ahn","year":"2023","journal-title":"N. Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.isci.2026.117376_bib33","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1038\/s41467-025-60649-w","article-title":"Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinoma","volume":"16","author":"Sun","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117376_bib34","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s12094-024-03722-y","article-title":"Combining serum CDK1 with tumor markers for the diagnosis of small cell lung cancer","volume":"27","author":"Han","year":"2025","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.isci.2026.117376_bib35","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.3233\/TUB-230016","article-title":"Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission","volume":"46","author":"Muley","year":"2024","journal-title":"Tumour Biol."},{"key":"10.1016\/j.isci.2026.117376_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00418-020-01863-z","article-title":"Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells","volume":"153","author":"Kudoh","year":"2020","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.isci.2026.117376_bib37","article-title":"Assessment of targets of antibody drug conjugates in SCLC","volume":"9","author":"Ajay","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.isci.2026.117376_bib38","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jtho.2021.08.763","article-title":"Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers","volume":"17","author":"Qu","year":"2022","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.isci.2026.117376_bib39","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.21037\/tcr-24-1755","article-title":"Targeting the EZH2-SLFN11 pathway-a lesson in developing molecularly-informed treatments for recurrent small cell lung cancer","volume":"13","author":"Sun","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.isci.2026.117376_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41416-022-01811-9","article-title":"Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer","volume":"127","author":"Zhang","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2026.117376_bib41","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.21037\/tlcr-21-437","article-title":"SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer","volume":"10","author":"Kundu","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.isci.2026.117376_bib42","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1158\/1078-0432.CCR-24-2556","article-title":"Synergistic Effects of ATR Inhibition and Lurbinectedin in Soft-Tissue Sarcomas: The Predictive Role of SLFN11 Expression","volume":"31","author":"Laroche-Clary","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117376_bib43","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/0008-5472.CAN-16-2983","article-title":"Temozolomide in the Era of Precision Medicine","volume":"77","author":"Thomas","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.117376_bib44","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217313","article-title":"ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer","volume":"15","author":"Schultz","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2026.117376_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.isci.2026.117376_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.117376_bib47","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.117376_bib48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: An update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.isci.2026.117376_bib49","doi-asserted-by":"crossref","first-page":"djw122","DOI":"10.1093\/jnci\/djw122","article-title":"Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression","volume":"108","author":"Polley","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.isci.2026.117376_bib50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41568-025-00803-0","article-title":"Challenges of small cell lung cancer heterogeneity and phenotypic plasticity","volume":"25","author":"Simpson","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117376_bib51","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ccell.2021.09.008","article-title":"Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer","volume":"39","author":"Chan","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.117376_bib52","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/s41467-022-29517-9","article-title":"Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models","volume":"13","author":"Lissa","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117376_bib53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s43018-019-0020-z","article-title":"Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer","volume":"1","author":"Stewart","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2026.117376_bib54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.21037\/tlcr.2018.02.02","article-title":"Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes","volume":"7","author":"Zhang","year":"2018","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.isci.2026.117376_bib55","article-title":"Basal cell of origin resolves neuroendocrine\u2013tuft lineage plasticity in cancer","author":"Ireland","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2026.117376_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.779276","article-title":"Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity","volume":"12","author":"Qi","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.isci.2026.117376_bib57","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.celrep.2016.06.081","article-title":"ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs","volume":"16","author":"Borromeo","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2026.117376_bib58","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1158\/1078-0432.CCR-23-3383","article-title":"A Phase I\/II Study of Valemetostat (DS-3201b), an EZH1\/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer","volume":"30","author":"Choudhury","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117376_bib59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13045-023-01464-y","article-title":"Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer","volume":"16","author":"Rudin","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2026.117376_bib60","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41568-024-00690-x","article-title":"Cancer therapy with antibodies","volume":"24","author":"Paul","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.117376_bib61","doi-asserted-by":"crossref","first-page":"D1097","DOI":"10.1093\/nar\/gkad831","article-title":"ADCdb: the database of antibody-drug conjugates","volume":"52","author":"Shen","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.117376_bib62","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1158\/1078-0432.CCR-20-3396","article-title":"Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5-SN38 Antibody-drug Conjugate in Neuroendocrine Prostate Cancer","volume":"27","author":"DeLucia","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.117376_bib63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5937\/jomb0-37083","article-title":"Analysis of variation of serum CEA, SCC, CYFRA21-1 in patients with lung cancer and their diagnostic value with EBUS-TBNA","volume":"43","author":"Du","year":"2024","journal-title":"J. Med. Biochem."},{"key":"10.1016\/j.isci.2026.117376_bib64","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12672-024-01323-3","article-title":"A comparative study of ProGRP and CEA as serological markers in small cell lung cancer treatment","volume":"15","author":"Yu","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.isci.2026.117376_bib65","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185423","article-title":"NOTCH1 reverses immune suppression in small cell lung cancer through reactivation of STING","volume":"135","author":"Kim","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.117376_bib66","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1038\/s41467-021-24164-y","article-title":"Notch signaling and efficacy of PD-1\/PD-L1 blockade in relapsed small cell lung cancer","volume":"12","author":"Roper","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.117376_bib67","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226027549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226027549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:15:36Z","timestamp":1791594936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226027549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2589004226027549"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.117376","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SCLC TumorMiner: A genomics platform for small cell lung cancer precision oncology","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.117376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117376"}}